Coriell Life Sciences Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 28
Employees
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 2

Coriell Life Sciences General Information

Description

Developer of a healthcare management system designed to securely access expert interpretations when needed. The company's healthcare management system offers storage of genomic data, expert interpretation and an interchange framework that integrates genomic data into healthcare management, enabling healthcare professionals to deliver clinically-relevant genomic interpretation at the point-of-care.

Contact Information

Website
www.coriell.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 4747 South Broad Street
  • Building 101, Suite 222
  • Philadelphia, PA 19112
  • United States
+1 (888) 000-0000

Coriell Life Sciences Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Coriell Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Debt - PPP 15-Apr-2020 000.00 Completed Generating Revenue
7. Later Stage VC (Series A) 06-May-2019 00.00 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series A) 28-Jun-2017 0000 Cancelled Generating Revenue
5. Seed Round 02-Feb-2017 00.00 00.00 000.00 Completed Generating Revenue
4. Seed Round 07-Feb-2014 00.00 00.00 0000 Completed Startup
3. Accelerator/Incubator 20-Sep-2013 000 Completed Startup
2. Debt - General 22-Jun-2013 $1M $1M Completed Startup
1. Equity Crowdfunding Completed Startup
To view Coriell Life Sciences’s complete valuation and funding history, request access »

Coriell Life Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 3 0,000,000 00.000000 00.00 00.00 00 00.00 0.00
Seed 2 1,503,759 $0.000100 $1.33 $1.33 1x $1.33 12.31%
Seed 1 2,025,000 $0.000100 $0.99 $0.99 1x $0.99 16.58%
To view Coriell Life Sciences’s complete cap table history, request access »

Coriell Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a healthcare management system designed to securely access expert interpretations when needed. The company'
Biotechnology
Philadelphia, PA
28 As of 2021
000.00
000000000 - 000.00

00000000

quat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla p
0000 000000000
San Diego, CA
00 As of 0000
0000
00.00 0000-00-00
00000000000 0000

00000000

ate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proiden
0000000000000
Singapore, Singapore
00 As of 0000
00.000
00000 00000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Coriell Life Sciences Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AltheaDx Venture Capital-Backed San Diego, CA 00 0000 00000000000 0000
000000000000 Venture Capital-Backed Singapore, Singapore 00 00.000 00000 00000 00.000
0000000000000 0000 Corporation Bellevue, WA 00 000000000 -
00000 (0000000000 Venture Capital-Backed Burlingame, CA 000 00000 0000000000 0 00000
00000000 000000 Formerly VC-backed Mason, OH 000 00000 000000&0 00000
You’re viewing 5 of 5 competitors. Get the full list »

Coriell Life Sciences Executive Team (7)

Name Title Board Seat Contact Info
Scott Megill Chief Executive Officer, President & Board Member
William Testa Chief Financial Officer
Steve Kradel Chief Technology Officer
Jennifer Ferrang Chief Revenue Officer
Jeffrey Shaman Ph.D Chief Scientific Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Coriell Life Sciences Board Members (5)

Name Representing Role Since
Peter Silvester Thermo Fisher Scientific Board Member 000 0000
Robert Kiep III Self Board Member 000 0000
Scott Megill Coriell Life Sciences Chief Executive Officer, President & Board Member 000 0000
Stephen Andriole Self Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Coriell Life Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Coriell Life Sciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Thermo Fisher Scientific Corporation Minority 000 0000 000000 0
IBM SmartCamp Accelerator/Incubator 000 0000 000000 0
To view Coriell Life Sciences’s complete investors history, request access »